The PI3K/Akt signaling has been reported to activate the expression of the DOX efflux transporters MDR1 (P-gp) in breast and gastric cancer cells [36], [37] and of MRP1 in AML [38] and in prostate carcinoma cells [39]. Here, AKT1 is linked to prostate carcinoma.